Guardant Health Diagnoses Breakout Move

In addition to touchdown on the IBD 50 checklist of growth shares to watch. Guardant Health (GH) has also earned a spot on the Investor’s Business Daily Leaderboard. And a latest approval of its Guardant360 CDx by the U.S. Food and Drug Administration have shares of the precision oncology firm testing a buy zone. Earlier this month, the FDA permitted…